Report Highlights

U.S. Supplement Market: Market Overview

The U.S. vitamin and mineral supplement market is the largest national market for these products worldwide, with retail sales estimated at USD 17.9 billion in 2024. Its structure departs from global norms. The Dietary Supplement Health and Education Act of 1994 lets products reach shelves without premarket FDA approval, so brands compete on claims, channel access and price rather than regulatory barriers. Most units sell through mass retail, pharmacies and e-commerce.

Demand is anchored in mainstream consumers rather than niche users, and roughly half of American adults report taking a dietary supplement regularly, according to NIH Office of Dietary Supplements survey data. American labelling permits structure and function claims, such as supporting bone health, which the European Union restricts under Regulation 1924/2006. That permissive claims environment sustains a high-volume, marketing-led category with a larger retail footprint than any other national market.

Growth Drivers in the U.S. Supplement Market

The population aged 65 and older, now roughly 58 million people, drives steady demand for calcium, vitamin D and vitamin B12 products. The 2020–2025 Dietary Guidelines for Americans identify vitamin D, calcium, potassium and fiber as nutrients of public health concern, which reinforces supplement purchasing among adults who fall short of recommended intake. The HHS Make America Healthy Again agenda, launched in 2025, keeps federal attention on diet-related chronic disease.

Subscription commerce and at-home testing have created a second demand engine. Amazon Subscribe & Save and Walmart+ convert one-time buyers into monthly purchasers, while at-home biomarker firms such as Everlywell and Function Health translate blood results into targeted vitamin D, B12 and iron recommendations. Retailer private labels, including Costco's Kirkland Signature and Walmart's Equate, expand the entry-price tier and broaden the household base for the category.

Market Restraints and Entry Barriers

Post-launch enforcement is the most material operating risk. The FDA can remove adulterated or misbranded products from market, and California's Proposition 65 requires warnings for lead and other listed substances, a recurrent issue in mineral and botanical formulations. Most vitamin raw materials, including ascorbic acid, are sourced from China, so Section 301 tariffs and 2025 reciprocal tariffs raise landed input costs for importers of bulk ingredients.

Incumbent shelf positions form the second barrier. Haleon's Centrum and Bayer's One A Day hold long-established placement in Walmart, Target and CVS aisles, and Costco's Kirkland Signature line sets price benchmarks that compress margins for new brands. Mass retailers typically require slotting fees, promotional funding and extended payment terms, which raise the capital needed to reach national distribution beyond digital channels.

Market Opportunities in the U.S.

Adults aged 55 and older represent the most accessible near-term opportunity, with an analyst estimate of USD 6.5 billion in annual retail spend on bone, cardiovascular and cognitive-support products. Entrants can target this cohort through pharmacy chains, including CVS and Walgreens, where pharmacist recommendation influences purchase. Products combining vitamin D3 with calcium citrate and magnesium glycinate fit established claim language.

Magnesium is the fastest-growing mineral category, driven by sleep and stress positioning on shelves at Target and Walmart and in direct-to-consumer subscription bundles. Gummy and powder formats, which command price premiums of 20 to 30 percent over capsules, also expand reach among younger adults who avoid pills. Brands that secure third-party certification and transparent heavy-metal testing gain an advantage with retailers adopting stricter audit standards.

Market at a Glance

Leading Market Participants

• Haleon
• Bayer
• Abbott
• Nature's Bounty Co.
• Nestlé Health Science
• Herbalife
• Amway
• USANA Health Sciences
• GNC
• Vitamin Shoppe

Regulatory and Policy Environment

The Dietary Supplement Health and Education Act of 1994 is the foundational statute, and the FDA enforces it alongside the Federal Food, Drug, and Cosmetic Act. Manufacturers must comply with current good manufacturing practice rules under 21 CFR Part 111, and file a structure and function claim notification within 30 days of first marketing under 21 CFR 101.93. The Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006 requires serious adverse event reports within 15 business days.

New dietary ingredients require premarket notification under 21 U.S.C. 350b at least 75 days before marketing, which delays launches of novel mineral chelates or botanicals. The Federal Trade Commission pursues unsubstantiated health claims under Section 5 of the FTC Act, including those in supplement advertising. The U.S. government offers no direct subsidies to supplement makers, while the NIH Office of Dietary Supplements funds research but does not regulate product quality.

Long-Term Outlook for the U.S. Supplement Market

By 2032, the U.S. supplement market is projected to reach USD 26.9 billion, expanding at a 5.3% CAGR from the 2025 base year. Growth will concentrate in e-commerce and subscription channels, where recurring revenue offsets the margin pressure created by private-label expansion at Costco and Walmart. Brands with verified ingredient sourcing will outperform those relying on mass-market price competition.

Regulatory scrutiny will intensify around heavy metals, labelling accuracy and marketing claims as California's Proposition 65 enforcement and FTC substantiation standards tighten. Companies that invest in third-party testing through NSF International or USP certification will capture retailer listings most consistently. By 2032, the competitive field will be defined by a small number of scale players and a long tail of specialty brands with strong direct-to-consumer relationships.